These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7538862)

  • 1. Report from a Nordic workshop on CD34+ cell analysis: technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. Nordic Myeloma Study Group Laboratories.
    Johnsen HE
    J Hematother; 1995 Feb; 4(1):21-8. PubMed ID: 7538862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from the second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G).
    Johnsen HE; Knudsen LM
    J Hematother; 1996 Jun; 5(3):237-45. PubMed ID: 8817390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Nordic flow cytometry standard for CD34+ cell enumeration in blood and autografts: report from the third workshop. Nordic Stem Cell Laboratory Group.
    Johnsen HE; Baech J; Nikolajsen K
    J Hematother; 1999 Feb; 8(1):15-28. PubMed ID: 10192298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry.
    Read EJ; Kunitake ST; Carter CS; Chau Q; Yu MY; Klein HG
    J Hematother; 1997 Aug; 6(4):291-301. PubMed ID: 9377067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
    Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods.
    Gajkowska A; Oldak T; Jastrzewska M; Machaj EK; Walewski J; Kraszewska E; Pojda Z
    Folia Histochem Cytobiol; 2006; 44(1):53-60. PubMed ID: 16584093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recruitment of CD34+ cells during large-volume leukapheresis.
    Moller AK; Dickmeiss E; Geisler CH; Christensen LD
    J Hematother Stem Cell Res; 2001 Dec; 10(6):837-53. PubMed ID: 11798510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assurance of CD34+ cell estimation in leucapheresis products.
    Lumley MA; McDonald DF; Czarnecka HM; Billingham LJ; Milligan DW
    Bone Marrow Transplant; 1996 Oct; 18(4):791-6. PubMed ID: 8899197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.
    Kiel K; Cremer FW; Ehrbrecht E; Wallmeier M; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1998 Jun; 21(11):1109-15. PubMed ID: 9645573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cells.
    Cremer FW; Kiel K; Sucker C; Wacker J; Atzberger A; Haas R; Goldschmidt H; Moos M
    Leukemia; 1997 Dec; 11 Suppl 5():S41-6. PubMed ID: 9436938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets.
    Chin-Yee IH; Keeney M; Stewart AK; Belch A; Bence-Buckler I; Couban S; Howson-Jan K; Rubinger M; Stewart D; Sutherland R; Paragamian V; Bhatia M; Foley R
    Bone Marrow Transplant; 2002 Dec; 30(12):851-60. PubMed ID: 12476276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts.
    de Boer F; Dräger AM; Pinedo HM; Kessler FL; Monnee-van Muijen M; Weijers G; Westra G; van der Wall E; Netelenbos T; Oberink JW; Huijgens PC; Schuurhuis GJ
    J Hematother Stem Cell Res; 2002 Dec; 11(6):951-63. PubMed ID: 12590710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primitive multilineage progenitor cells predominate in peripheral blood early after mobilization with high-dose cyclophosphamide and GM-CSF or G-CSF.
    Croockewit S; Raymakers R; Trilsbeek C; Dolstra H; Pennings A; de Witte T
    Leukemia; 1994 Dec; 8(12):2194-9. PubMed ID: 7528861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
    Sovalat H; Racadot E; Ojeda M; Lewandowski H; Chabouté V; Hénon P
    J Hematother Stem Cell Res; 2003 Oct; 12(5):473-89. PubMed ID: 14594504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts.
    Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G
    J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of hematopoietic progenitor cell count determined by the SE-automated hematology analyzer with CD34(+) cell count by flow cytometry in leukapheresis products.
    Park KU; Kim SH; Suh C; Kim S; Lee SJ; Park JS; Cho HJ; Kim KW; Lee K; Kim HJ; Park J; Joo Min Y; Kim JG; Kim T; Lee JH; Kim SB; Kim SW; Lee KH; Lee JS; Kim WK; Park CJ; Chi HS
    Am J Hematol; 2001 May; 67(1):42-7. PubMed ID: 11279656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis.
    Rinn JP; Schwella N; Wollmer E; Jaques G; Heinzel-Gutenbrunner M; Strassmann G; Gross MW; Movassaghi K; Neubauer A; Ritter M
    Ann Hematol; 2006 Jan; 85(1):38-44. PubMed ID: 16012838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy.
    Teixeira G; Lenormand B; Jean P; Fardoun D; Sumereau-Dassin E; Bastit D; Tilly H; Piguet H; Monconduit M; Vannier JP
    Am J Hematol; 1992 Mar; 39(3):172-5. PubMed ID: 1372150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.